EyePoint, Inc. - Common Stock (NQ:EYPT)

3.250 +0.020 (+0.62%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about EyePoint, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

20 Stocks Moving in Monday's Pre-Market Session ↗

November 15, 2021

Gainers Creative Realities, Inc. (NASDAQ: CREX) rose 132.9% to $3.40 in pre-market trading as the company reported a merger with Reflect Systems on Friday. Bit Brother Limited (...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

EyePoint Sets its Sights on Developing Treatments Improving the Lives of Eye Disease Sufferers ↗

September 30, 2021

Photo Credit: EyePoint Pharmaceuticals Companies dedicated to improving the lives of the 2.2 billion people suffering from eye diseases are making incredible strides in developing...

Via Benzinga

EyePoint Sets its Sights on Continued Trial Success in Developing Treatments Improving the Lives of Eye Disorder Sufferers ↗

September 14, 2021

Photo by Brands&People on Unsplash Companies dedicated to improving the lives of the 2.2 billion people suffering from eye disorders are making incredible strides in...

Via Benzinga

EyePoint Pharmaceuticals: Q1 Earnings Insights ↗

May 05, 2021

Shares of EyePoint Pharmaceuticals (NASDAQ:EYPT) moved higher by 2.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share...

Via Benzinga

EyePoint Pharmaceuticals's Earnings Outlook ↗

May 04, 2021

On Wednesday, May 05, EyePoint Pharmaceuticals (NASDAQ:EYPT) will release its latest earnings report. Decipher the announcement with Benzinga's help. What Are Earnings, Net...

Via Benzinga

If You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing ↗

April 26, 2021

In this crazy Reddit-driven stock market, it's still important to understand why OCGN stock is hot. And why it's dangerous.

Via InvestorPlace

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.